Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Gains from Sales and Divestitures: 2013-2024

Historic Gains from Sales and Divestitures for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to $388,816.

  • Amphastar Pharmaceuticals' Gains from Sales and Divestitures fell 4.23% to $372,218 in Q3 2025 from the same period last year, while for Sep 2025 it was $372,218, marking a year-over-year decrease of 4.23%. This contributed to the annual value of $388,816 for FY2024, which is 11.73% down from last year.
  • According to the latest figures from FY2024, Amphastar Pharmaceuticals' Gains from Sales and Divestitures is $388,816, which was down 11.73% from $440,484 recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Gains from Sales and Divestitures peaked at $628,054 during FY2020, and registered a low of $388,816 during FY2024.
  • For the 3-year period, Amphastar Pharmaceuticals' Gains from Sales and Divestitures averaged around $435,789, with its median value being $440,484 (2023).
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Gains from Sales and Divestitures climbed by 15.56% in 2020, and later declined by 21.39% in 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Gains from Sales and Divestitures (Yearly) stood at $628,054 in 2020, then dropped by 21.39% to $493,718 in 2021, then fell by 3.17% to $478,068 in 2022, then dropped by 7.86% to $440,484 in 2023, then declined by 11.73% to $388,816 in 2024.